ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2026
Antibacterial potential of danthron, embelin, sanguinarine and shikonin against multidrug-resistant Neisseria gonorrhoeae in vitro.
Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundNeisseria gonorrhoeae (N. gonorrhoeae) poses a public health challenge due to escalating incidence and growing antimicrobial resistance, necessitating urgent exploration of alternative therapies. Presently, clinical management relies on ceftriaxone monotherapy or its combination with azithromycin. However, emergence and spread of strains resistant to previously recommended regimens, particularly the FC428 clone strain, which also exhibits azithromycin resistance, present significant challenges. Therefore, investigation of alternative strategies is paramount.
methods55 multidrug-resistant N. gonorrhoeae isolates, including those with high-level resistance to ceftriaxone, high-level resistance to azithromycin, and dual-resistant clones, were collected from Guangdong province between 2017 and 2021. Drug susceptibility of natural products was assessed using broth microdilution methods. Cytotoxicity of the four natural products against renal epithelial (293T) and human vaginal epithelial (VK2/E6E7) cells was evaluated by Cell Counting Kit-8 assay.
resultsOur findings indicated that danthron exhibited good antibacterial activity, followed by embelin, sanguinarine and shikonin, with MIC 50/90 values of 2.4/4.8, 3/6, 3.3/6.6 and 6/12 mg/L, respectively. These results indicated that even low concentrations could effectively inhibit growth of N. gonorrhoeae. Furthermore, all four natural products demonstrated potent antibacterial effects against dangerous strains, including those exhibiting ceftriaxone resistance (MIC ≥ 0.125 mg/L), high-level azithromycin resistance (MIC ≥ 256 mg/L), or dual-resistance characteristics. Additionally, preliminary toxicological assessments on cell lines suggested the following order of selective toxicity: danthron < embelin < sanguinarine < shikonin.
conclusionDanthron, embelin, sanguinarine and shikonin demonstrated preliminary effectiveness in eliminating multidrug-resistant N. gonorrhoeae with appropriate selective toxicity. Our study suggests they may represent promising candidates for further investigation and potential therapeutic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.